USFDA concludes inspection at Gland Pharma’s Pashamylaram Facility

26 Sep 2023 Evaluate

Gland Pharma has received Establishment Inspection Report (EIR) from the USFDA indicating closure of the inspection, following the Pre-Approval Inspection (PAI) for seven products and Good Manufacturing Practice (GMP) Inspection by USFDA at the Company’s Pashamylaram Facility at Hyderabad between June 15, 2023 and June 27, 2023.

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.


Gland Pharma Share Price

1647.90 -5.45 (-0.33%)
29-Dec-2025 13:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.45
Dr. Reddys Lab 1264.70
Cipla 1497.00
Zydus Lifesciences 903.70
Lupin 2084.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×